| 发明名称 | Treatment of cystic diseases | ||
| 摘要 | The invention described herein pertains to the treatment of cystic diseases. More particularly, the invention described herein relates to methods for treating cystic disease using one or more lysophosphatidic acid antagonists, TMEM16a inhibitors, and/or peroxisome proliferator-activated receptor modulators. | ||
| 申请公布号 | US9579335(B2) | 申请公布日期 | 2017.02.28 |
| 申请号 | US201514853216 | 申请日期 | 2015.09.14 |
| 申请人 | Indiana University Research and Technology Corporation | 发明人 | Blazer-Yost Bonnie |
| 分类号 | A01N57/00;A61K31/675;A61K31/7024;A61K45/06 | 主分类号 | A01N57/00 |
| 代理机构 | Stinson Leonard Street LLP | 代理人 | Stinson Leonard Street LLP |
| 主权项 | 1. A method for reducing electrolyte and fluid secretion in a patient having or suspected of having a cystic disease, the method comprising the step of administering to the patient (a) an effective amount of one or more TMEM16a inhibitors; and (b) an effective amount of one or more lysophosphatidic acid antagonists, or an effective amount of one or more PPAR gamma agonists, or a combination thereof. | ||
| 地址 | Indianapolis IN US | ||